NuclixBio
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.nuclixbio.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
About NuclixBio
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NuclixBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on NuclixBio recently announced quarterly report
Check out if NuclixBio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at NuclixBio
Funding: Get notified immidiatlly once NuclixBio has new funding data
Website visits: Recent activity has been detected on your website
Check if NuclixBio has recently received funding, and reach out quickly before it becomes old news!
Click to see if NuclixBio had a recent Job posting/layoffs
Product Launch: Get notified when NuclixBio launches new products
NuclixBio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
NuclixBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NuclixBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NuclixBio.
NuclixBio Tech Stack
A closer look at the technologies used by NuclixBio
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding NuclixBio
NuclixBio, Inc. is a pre-clinical stage biotech company focusing on early-stage research and development of intracellularly targeted nucleic acid therapeutics that are based on proprietary platform technologies. With its own circular mRNA platform ringRNA, NuclixBio has established additional strong therapeutics platform such as Ribo-TaP and Ribo-g... Read More
